- Home
- TCRX vs MLSS Comparison
TCRX vs MLSS Comparison
Compare TCRX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- MLSS
- Stock Information
- Founded
- TCRX 2018
- MLSS 1989
- Country
- TCRX United States
- MLSS United States
- Employees
- TCRX N/A
- MLSS N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- TCRX Health Care
- MLSS Health Care
- Exchange
- TCRX Nasdaq
- MLSS Nasdaq
- Market Cap
- TCRX 115.8M
- MLSS 94.2M
- IPO Year
- TCRX 2021
- MLSS 1995
- Fundamental
- Price
- TCRX $2.17
- MLSS $1.04
- Analyst Decision
- TCRX Strong Buy
- MLSS Buy
- Analyst Count
- TCRX 5
- MLSS 1
- Target Price
- TCRX $11.40
- MLSS $1.25
- AVG Volume (30 Days)
- TCRX 382.5K
- MLSS 118.7K
- Earning Date
- TCRX 03-05-2025
- MLSS 03-31-2025
- Dividend Yield
- TCRX N/A
- MLSS N/A
- EPS Growth
- TCRX N/A
- MLSS N/A
- EPS
- TCRX N/A
- MLSS N/A
- Revenue
- TCRX $9,362,000.00
- MLSS $8,877,010.00
- Revenue This Year
- TCRX N/A
- MLSS N/A
- Revenue Next Year
- TCRX $5.14
- MLSS $17.97
- P/E Ratio
- TCRX N/A
- MLSS N/A
- Revenue Growth
- TCRX N/A
- MLSS N/A
- 52 Week Low
- TCRX $1.99
- MLSS $0.54
- 52 Week High
- TCRX $9.69
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- TCRX 37.12
- MLSS 38.03
- Support Level
- TCRX $2.02
- MLSS $1.14
- Resistance Level
- TCRX $2.17
- MLSS $1.21
- Average True Range (ATR)
- TCRX 0.16
- MLSS 0.08
- MACD
- TCRX 0.02
- MLSS -0.03
- Stochastic Oscillator
- TCRX 26.47
- MLSS 15.15
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.